High dose ascorbic acid treatment in COVID-19 patients raised some problems in clinical chemistry testing

Yesildal F., İŞMAN F. K.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.45, sa.5, ss.491-498, 2020 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 45 Konu: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1515/tjb-2020-0237
  • Dergi Adı: TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
  • Sayfa Sayıları: ss.491-498

Özet

Objective: COVID-19 pandemia still continues to threaten the whole world. High dose ascorbic acid (AA) infusion is a choice of treatment and its efficiency is still being investigated. AA interferes with many clinical chemistry tests. However, data about the interference of high concentrations of AA is not sufficient. In this study, we aimed to investigate the interference of AA at high concentrations on commonly used chemistry assays.